Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
55.11
+0.04 (0.07%)
At close: Apr 28, 2026, 4:00 PM EDT
55.11
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Inspire Medical Systems stock have an average target of 94, with a low estimate of 62 and a high estimate of 175. The average target predicts an increase of 70.57% from the current stock price of 55.11.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 6 | 7 | 6 | 4 | 4 | 4 |
| Hold | 5 | 6 | 7 | 10 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $70 → $64 | Hold | Maintains | $70 → $64 | +16.13% | Apr 15, 2026 |
| Mizuho | Mizuho | Buy Maintains $85 → $70 | Buy | Maintains | $85 → $70 | +27.02% | Apr 13, 2026 |
| Stifel | Stifel | Strong Buy Maintains $85 → $70 | Strong Buy | Maintains | $85 → $70 | +27.02% | Apr 10, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $85 → $62 | Buy | Maintains | $85 → $62 | +12.50% | Apr 6, 2026 |
| Stifel | Stifel | Strong Buy Maintains $95 → $85 | Strong Buy | Maintains | $95 → $85 | +54.24% | Mar 5, 2026 |
Financial Forecast
Revenue This Year
985.08M
from 911.98M
Increased by 8.02%
Revenue Next Year
1.07B
from 985.08M
Increased by 8.11%
EPS This Year
1.99
from 4.89
Decreased by -59.22%
EPS Next Year
2.64
from 1.99
Increased by 32.45%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.0B | 1.1B | ||||||
| Avg | 985.1M | 1.1B | ||||||
| Low | 926.0M | 972.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.7% | 15.3% | ||||||
| Avg | 8.0% | 8.1% | ||||||
| Low | 1.5% | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 2.34 | 3.56 | ||||
| Avg | 1.99 | 2.64 | ||||
| Low | 1.38 | 1.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -52.1% | 78.5% | ||||
| Avg | -59.2% | 32.5% | ||||
| Low | -71.7% | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.